3.23
5.56%
-0.19
Handel nachbörslich:
3.39
0.16
+4.95%
Finanzdaten der Maxcyte Inc-Aktie (MXCT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
27.59%
11.34
|
15.66 | 8.0045 | 9.0426 | 8.5763 |
Cost Of Revenue |
10.81%
1.403
|
1.5731 | 0.7934 | 1.3757 | 0.9998 |
Gross Profit |
29.47%
9.939
|
14.09 | 7.2111 | 7.6669 | 7.5765 |
Operating Expenses
|
0.12%
22.21
|
22.19 | 21.16 | 20.74 | 20.75 |
Benefits Costs and Expenses |
0.36%
20.87
|
20.94 | - | - | 19.46 |
Costs And Expenses |
0.36%
20.87
|
20.94 | 21.96 | 22.12 | 19.46 |
Depreciation and Amortization |
0.48%
1.068
|
1.0629 | 1.0325 | 0.9774 | 0.9122 |
Operating Income/Loss |
51.62%
-12.28
|
-8.0957 | -13.95 | -13.07 | -13.18 |
Income/Loss From Continuing Operations Before Tax |
80.49%
-9.526
|
-5.2778 | 8.0045 | -10.51 | -10.88 |
Income/Loss From Continuing Operations After Tax |
80.49%
-9.526
|
-5.2778 | -11.25 | -10.51 | -10.88 |
Net Income/Loss
|
80.49%
-9.526
|
-5.2778 | -11.25 | -10.51 | -10.88 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
70,949%
104.09
|
0.1465 | 103.45 | 103.06 | 102.85 |
Basic Earnings Per Share |
80.00%
-0.09
|
-0.05 | -0.11 | -0.10 | -0.11 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):